Description
Exemestane is listed in the oncology-focused API portfolio. The page is a technical overview only; clinical, regulatory and commercial status must be established from approved product documentation.
← Back to all products
Oncology API / Pharmaceutical technical profile
Exemestane
(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione
Category: Oncology APICAS No.: 107868-30-4Formula: C20H24O2
Swati Industries portfolio01 02 03
Chemical & technical profile
Product nameExemestane
CategoryOncology API
CAS No.107868-30-4
Molecular formulaC20H24O2
Molecular weight296.4 g/mol
PubChem CID60198
Research & Development
Impurity identification and fate mapping; genotoxic-impurity risk assessment where relevant; robust assay/related-substances methods; solid-state characterization; stability and packaging studies.
Analytical testing
Identity by IR/LC-MS/NMR; assay and related substances by HPLC/UPLC; residual solvents by GC; water content; XRPD/DSC and particle-size testing where specification-relevant.
Verified chemical reference
(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione
Open PubChem reference ↗Technical overview only; not a validated manufacturing process or a claim of company capability. Confirm chemical form, CAS No., grade and specifications from the approved specification and batch COA.